IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats
- 1 November 1993
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 265 (5) , E770-E776
- https://doi.org/10.1152/ajpendo.1993.265.5.e770
Abstract
Effects induced by insulin-like growth factor I (IGF-I) and/or the bisphosphonate pamidronate (APD) on bone mineral density (BMD) of the lumbar spine and proximal and midshaft tibia were studied in adult rats made osteopenic by ovariectomy, using dual-energy X-ray absorptiometry. IGF-I, which was administered by osmotic minipumps implanted subcutaneously for 6 wk, caused a dose-dependent increase of BMD at the three investigated sites. A 4-wk course of IGF-I, followed by intermittent cyclical APD administration, induced significant increases of BMD at the levels of spine and proximal tibia. At midshaft tibia, where cortical bone predominates, BMD was increased by IGF-I only. In conclusion, IGF-I increased BMD at sites with trabecular and/or cortical bone, whereas the APD influence was mainly detectable in the former site only.Keywords
This publication has 13 references indexed in Scilit:
- Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats.Endocrinology, 1992
- The anabolic action of 17β-estradiol (E2) on rat trabecular bone is suppressed by (3-amino-1-hydroxypropylidene)-1-bisphosphonate (AHPrBP)Bone and Mineral, 1992
- Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structureJournal of Bone and Mineral Research, 1992
- The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboonsJournal of Bone and Mineral Research, 1992
- In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in ratsBone, 1991
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Serum Insulin-like Growth Factor I (Somatomedin-C) Level in Normal Subjects from Infancy to Adulthood, Pituitary Dwarfs and Normal Variant Short Children.Endocrinologia Japonica, 1988
- Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the ratCalcified Tissue International, 1986
- Insulin-like growth factor I stimulates growth in hypophysectomized ratsNature, 1982